Company Profile: THC Global Group Ltd (ASX: THC), is a small cap company with focus on two core business units, including development and delivery of medicinal cannabis, and manufacturing and distribution of hydroponics equipment, materials and nutrients. The company has a strategy to become a global-scale vendor of medicinal cannabis. The company is undergoing acquisitions & expansion into many jurisdictions including Canada and has been into global sales business via USA and Europe.
Start discussion with value Investors for ASX Stock Market Investment and Opinion.
Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s
Those phrases have become increasingly common as marijuana legalization spreads.
Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.
Click here for your FREE Report